Biotech Hot Stock: CURR Expands Highly Valuable Medication Patent Portfolio; Marketing Expansion to Mexico

Mr. Berlent is an accomplished business growth executive with more than 25 years of private and public company experience focused on strategic partnerships and building businesses seeking to own end-to-end market verticals